Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effects in DIPG cells.
Saved in:
| Title: | Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effects in DIPG cells. |
|---|---|
| Authors: | Shen H; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia., Huynh QS; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia., Mudassar F; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia., Chang C; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia., Gloss B; Westmead Research Hub Core Facilities, Westmead Institute for Medical Research, Westmead, NSW, Australia., Ing P; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia., Ma S; Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention, The Ministry of Education, College of Pharmacy, Chongqing Medical University, Chongqing, China., Gee H; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.; Western Sydney Radiation Oncology Network, Sydney, NSW, Australia., Hau E; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia. Eric.Hau@health.nsw.gov.au.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia. Eric.Hau@health.nsw.gov.au.; Western Sydney Radiation Oncology Network, Sydney, NSW, Australia. Eric.Hau@health.nsw.gov.au., Cook KM; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia. kristina.cook@sydney.edu.au.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia. kristina.cook@sydney.edu.au.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia. kristina.cook@sydney.edu.au. |
| Source: | Cancer & metabolism [Cancer Metab] 2025 Oct 29; Vol. 13 (1), pp. 43. Date of Electronic Publication: 2025 Oct 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101607582 Publication Model: Electronic Cited Medium: Print ISSN: 2049-3002 (Print) Linking ISSN: 20493002 NLM ISO Abbreviation: Cancer Metab Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41163069 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effects in DIPG cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shen+H%22">Shen H</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Huynh+QS%22">Huynh QS</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.<br /><searchLink fieldCode="AU" term="%22Mudassar+F%22">Mudassar F</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.<br /><searchLink fieldCode="AU" term="%22Chang+C%22">Chang C</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.<br /><searchLink fieldCode="AU" term="%22Gloss+B%22">Gloss B</searchLink>; Westmead Research Hub Core Facilities, Westmead Institute for Medical Research, Westmead, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Ing+P%22">Ing P</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.<br /><searchLink fieldCode="AU" term="%22Ma+S%22">Ma S</searchLink>; Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention, The Ministry of Education, College of Pharmacy, Chongqing Medical University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Gee+H%22">Gee H</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.; Western Sydney Radiation Oncology Network, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Hau+E%22">Hau E</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia. Eric.Hau@health.nsw.gov.au.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia. Eric.Hau@health.nsw.gov.au.; Western Sydney Radiation Oncology Network, Sydney, NSW, Australia. Eric.Hau@health.nsw.gov.au.<br /><searchLink fieldCode="AU" term="%22Cook+KM%22">Cook KM</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia. kristina.cook@sydney.edu.au.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia. kristina.cook@sydney.edu.au.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia. kristina.cook@sydney.edu.au. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101607582%22">Cancer & metabolism</searchLink> [Cancer Metab] 2025 Oct 29; Vol. 13 (1), pp. 43. <i>Date of Electronic Publication: </i>2025 Oct 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101607582 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2049-3002 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220493002%22">20493002 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Metab <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41163069 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s40170-025-00411-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 43 Titles: – TitleFull: Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effects in DIPG cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shen H – PersonEntity: Name: NameFull: Huynh QS – PersonEntity: Name: NameFull: Mudassar F – PersonEntity: Name: NameFull: Chang C – PersonEntity: Name: NameFull: Gloss B – PersonEntity: Name: NameFull: Ing P – PersonEntity: Name: NameFull: Ma S – PersonEntity: Name: NameFull: Gee H – PersonEntity: Name: NameFull: Hau E – PersonEntity: Name: NameFull: Cook KM IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 10 Text: 2025 Oct 29 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2049-3002 Numbering: – Type: volume Value: 13 – Type: issue Value: 1 Titles: – TitleFull: Cancer & metabolism Type: main |
| ResultId | 1 |